Century Therapeutics (IPSC) Asset Utilization Ratio (2022 - 2025)
Century Therapeutics (IPSC) posted quarterly Asset Utilization Ratio of 0.47 for Q4 2025, up 2523.4% year-over-year from 0.02 in Q4 2024, and up 8.86% quarter-over-quarter from 0.43 in Q3 2025.
Powered by 
Analysis
Century Therapeutics (IPSC) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has reported Asset Utilization Ratio for 4 consecutive years, with 0.47 the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Utilization Ratio rose 2523.4% year-over-year to 0.47; the TTM figure through Dec 2025 stood at 0.47 (up 2523.4% YoY), while the FY2025 annual figure was 0.38, up 1950.15% from the prior year.
- Asset Utilization Ratio improved to 0.47 in Q4 2025 per IPSC's latest filing, from 0.43 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.47 in Q4 2025 and bottomed at 0.0 in Q1 2024.
- Historically, Asset Utilization Ratio has averaged 0.13 across 4 years, with a median of 0.01 in 2023.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio sank 68.93% — and 2025, when it jumped 8793.05%.
- Century Therapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then slumped by 43.4% to 0.01 in 2023, then soared by 201.38% to 0.02 in 2024, then jumped by 2523.4% to 0.47 in 2025.
- Business Quant data shows IPSC's Asset Utilization Ratio at 0.47 in Q4 2025, 0.43 in Q3 2025, and 0.38 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Century Therapeutics | 440.37 Mn | 180.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |